As research continues to expand the off-label use of GLP-1 therapy for other chronic disease conditions, how will you determine the long-term safety of these medications for your patient population
Semaglutide may be considered for patients who need GLP-1 support for appetite regulation and weight management
Many studies emphasize its capacity to upregulate endogenous antioxidant defenses and suppress oxidative stress in inflammatory and precancerous settings (Jakubczyk et al., 2020)
It maintains a healthy gut and is needed for blood formation
Blood work is not required, but if your medical history includes diabetes, prediabetes, or conditions that could complicate GLP-1 treatment, the provider may request lab work before prescribing
Cortisol and Prolactin Considerations Unlike ipamorelin, which selectively releases GH without affecting other pituitary hormones, GHRP-6 has a broader activation profile